Jordan Rubinson has over 20 years of experience in the pharmaceutical industry working with large pharma companies like Pfizer, GlaxoSmithKline, and Aventis More recently Mr Rubinson worked in early stage companies as Chief Commercial Officer for Champions Oncology where he grew sales 30% annually to $20M and profitability. Just prior Mr Rubinson was the CEO of Polyheal Ltd which was sold to TEVA at a $90M valuation. While in Pharma, Mr. Rubinson worked at Pfizer as the marketing director in Israel. At GSK in U.S. marketing, he managed assets of over $300M in annual sales, brought to market several category-leading vaccines, and earned the company Frost and Sullivan’s Market Engineering Excellence Award. He also worked in GSK France managing a large field force division of over 100 employees. While at Aventis, Mr. Rubinson had assignments in France, Canada and the U.S. Mr. Rubinson holds an engineering degree from Columbia University and an MBA from MIT’s Sloan School of Management.

Lipidology, Vascular biology, Immunology